Literature DB >> 30673834

Factors affecting epilepsy prognosis in patients with tuberous sclerosis.

Gülen Gül Mert1, Şakir Altunbaşak2, Özlem Hergüner2, Faruk İncecik2, Hilal Cansever Övetti2, Neslihan Özcan2, Duygu Kuşçu3, İlker Ünal4.   

Abstract

PURPOSE: We aimed to determine the characteristics of epileptic seizures that significantly affect the cognitive functions of 83 patients followed with tuberous sclerosis complex (TSC), their resistance to treatment and risk factors causing this resistance. MATERIALS-
METHODS: In order to determine the prognosis, the seizure-free/seizure-controlled group and the group with refractory seizures were compared. In addition, risk factors affecting cognitive functions in the patients were determined.
RESULTS: There was a statistical significance between the presence of a history of seizures in the neonatal period, the age of onset of seizures being less than 2 years of age, autism, status epilepticus, Lennox-Gastaut syndrome (LGS), presence of infantile spasm, generalization of the electroencephalography (EEG) findings, the number of tubers in cerebral imaging being more than three and refractory seizures (p < 0.05). Statistically significant relationship was found between presence of a history of seizures in the neonatal period, the age of onset of seizures, autism, LGS, presence of infantile spasm, presence of status epilepticus history, history of using more than three antiepileptic drugs, generalization of EEG findings, presence of SEGA in cerebral imaging, number of tubers being more than three and the patient's mental retardation (p < 0.05).
CONCLUSION: In logistic regression analysis, the age of the seizure onset being less than 2 years of age, the presence of autism and number of tubers being more than three in cerebral magnetic resonance imaging (MRI) are determined to be the risk factors that most likely to increase the seizures to be more resistant.

Entities:  

Keywords:  Epilepsy; Prognosis; Tuberous sclerosis

Year:  2019        PMID: 30673834     DOI: 10.1007/s00381-019-04066-7

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  25 in total

1.  The new ILAE classification.

Authors:  Shlomo Shinnar
Journal:  Epilepsia       Date:  2010-04       Impact factor: 5.864

2.  The risk of lower mental outcome in infantile spasms increases after three weeks of hypsarrhythmia duration.

Authors:  Zvonka Rener Primec; Janez Stare; David Neubauer
Journal:  Epilepsia       Date:  2006-12       Impact factor: 5.864

3.  The Tuberous Sclerosis 2000 Study: presentation, initial assessments and implications for diagnosis and management.

Authors:  John R W Yates; Cathy Maclean; J Nicholas P Higgins; Ayla Humphrey; Kate le Maréchal; Michelle Clifford; Iris Carcani-Rathwell; Julian R Sampson; Patrick F Bolton
Journal:  Arch Dis Child       Date:  2011-08-03       Impact factor: 3.791

4.  Association of tuberous sclerosis of temporal lobes with autism and atypical autism.

Authors:  P F Bolton; P D Griffiths
Journal:  Lancet       Date:  1997-02-08       Impact factor: 79.321

5.  Molecular basis of giant cells in tuberous sclerosis complex.

Authors:  David J Kwiatkowski; Brendan D Manning
Journal:  N Engl J Med       Date:  2014-08-21       Impact factor: 91.245

6.  Subependymal giant cell tumors in tuberous sclerosis complex.

Authors:  Suzanne Goh; William Butler; Elizabeth A Thiele
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

Review 7.  Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review.

Authors:  Lindsay Hallett; Talia Foster; Zhimei Liu; Marissa Blieden; Joice Valentim
Journal:  Curr Med Res Opin       Date:  2011-06-21       Impact factor: 2.580

8.  The natural history of epilepsy in tuberous sclerosis complex.

Authors:  Catherine J Chu-Shore; Philippe Major; Susana Camposano; David Muzykewicz; Elizabeth A Thiele
Journal:  Epilepsia       Date:  2009-12-22       Impact factor: 5.864

Review 9.  Tuberous sclerosis.

Authors:  Paolo Curatolo; Roberta Bombardieri; Sergiusz Jozwiak
Journal:  Lancet       Date:  2008-08-23       Impact factor: 79.321

10.  Clinical progress of epilepsy in children with tuberous sclerosis: prognostic factors for seizure outcome.

Authors:  Soo Min Park; Young Jin Lee; Young Joon Son; Young Ok Kim; Young Jong Woo
Journal:  Chonnam Med J       Date:  2011-12-26
View more
  2 in total

1.  Ketogenic Diet Therapy for Drug-Resistant Epilepsy and Cognitive Impairment in Children With Tuberous Sclerosis Complex.

Authors:  Yu Fang; Dan Li; Man Wang; Xia Zhao; Jing Duan; Qiang Gu; Baomin Li; Jian Zha; Daoqi Mei; Guangbo Bian; Man Zhang; Huiting Zhang; Junjie Hu; Liu Yang; Lifei Yu; Hua Li; Jianxiang Liao
Journal:  Front Neurol       Date:  2022-05-24       Impact factor: 4.086

Review 2.  Risk Factors Associated with Refractory Epilepsy in Patients with Tuberous Sclerosis Complex: A Systematic Review.

Authors:  Dominika Miszewska; Monika Sugalska; Sergiusz Jóźwiak
Journal:  J Clin Med       Date:  2021-11-24       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.